Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
Links shared publicly online about this topic.
- 1,129total visits
Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
BERLIN -- Systolic heart failure patients treated with candesartan (Atacand) had better one-year survival than those taking losartan (Cozaar) -- regardless of dose, comorbidities, or background heart
View full resource at medpagetoday.com
Tags: Heart, Heart Disease, Heart Failure, High Blood Pressure Medication, Cozaar, Hyzaar, Atacand, Blopress
Most Recently Shared on May 31, 2010 at 10:16 am By:
HFC: Registry Data Suggest Survival Benefit for Candesartan (CME/CE) http://ow.ly/17yPgv
Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “BERLIN -- Systolic heart failure patients treated with candesartan (Atacand) had better one-year survival than those taking losartan (Cozaar) -- regardless of dose, comorbidities, or background heart” View full resource at medpagetoday.com
Most Recently Shared on May 31, 2010 at 2:43 am By:
Patricia Grace Eldercare Expert
HFC: Registry Data Suggest Survival Benefit for Candesartan (CME/CE): BERLIN (MedPage Today) -- Systolic heart fai... http://bit.ly/cdVbqJ
Advertisement
